Anika Therapeutics resumes distribution of cartilage regeneration treatments

Biologics

Anika Therapeutics resumed distribution of its solid hyaluronic acid-based treatments after a voluntary, non-safety related recall in the second quarter.

Here are four things to know:

1. The regenerative medicine company resumed global distribution of Hyalofast, Hyalograft-C and Hyalomatrix.

2. Hyalofast is a biodegradable HA-based scaffold for hyaline-like cartilage regeneration to treat cartilage defects and injuries.

3. Following recent regulatory approvals in Thailand, the United Arab Emirates and Colombia, Hyalofast is now used in 15 countries.

4. Anika Therapeutics develops, manufactures and commercializes more than 20 products based on its proprietary HA technology.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers